Skip to content Skip to footer
Subscribe Now
Exclusive_Kevin Cammack1_Mark Warren2_2021
EXCLUSIVE

Exclusive Interview with PharmaShots: Kevin Cammack and Mark Warren Share Insight on Lyumjev U-100 Approved for Use in Insulin Pumps

In an interview with PharmaShots, Kevin Cammack, Head of Connected Care, Eli Lilly, and Mark Warren, MD, Director of Endocrine Clinical Trials and Laboratory Services, Physicians East share their views on the US FDA’s approval of rapid-acting insulin, Lyumjev (insulin lispro-aabc injection) 100 units/mL indicated to improve glycemic control in adults with type 1 and type 2…
October 4, 2021

Read more

Viewpoints_Kevin Cammack
VIEWPOINTS

PharmaShots Interview: Eli Lilly’s Kevin Cammack Shares Insights on Lilly’s Collaboration with Global Diabetes Technology Companies

In an interview with PharmaShots, Kevin Cammack, Head of Connected Care, Eli Lilly and Company shares insights on the Lilly alliance with DexCom, Glooko, myDiabby Healthcare, and Roche to provide compatibility between their unique digital management platforms and Lilly's Tempo Pen and Tempo Smart Button. Shots: Eli Lilly collaborates with DexCom, Glooko, myDiabby Healthcare, and Roche to…
June 28, 2021

Read more